Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 2 1 Phase 1 1

Status

Completed 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 7 Cyclophosphamide 6 pembrolizumab 5 Radiosurgery 5 Nivolumab 4 Fluorouracil 4 Carboplatin 4 Blood Specimen Collection 4 Biopsy 4 X-Rays 3 Vincristine 3 Surveys and Questionnaires 3 Proflavine 3 Positron-Emission Tomography 3 Metformin 3 Cisplatin 3 Bevacizumab 3 fludarabine phosphate 2 durvalumab 2 atezolizumab 2 Varenicline 2 Topotecan 2 Taxes 2 Specimen Handling 2 Rituximab 2 Radiotherapy 2 Positron Emission Tomography Computed Tomography 2 Oxaliplatin 2 Leucovorin 2 Letrozole 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Terminated × Omeprazole × Clear all

NCT04930991 2026-06-01

OU202005AJ

University of Oklahoma

Phase EARLY_PHASE1 Terminated

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡